BenQ Medical Technology Corporation

TPEX:4116 Rapport sur les actions

Capitalisation boursière : NT$2.1b

BenQ Medical Technology Bilan de santé

Santé financière contrôle des critères 5/6

BenQ Medical Technology possède un total de capitaux propres de NT$2.3B et une dette totale de NT$1.4B, ce qui porte son ratio d'endettement à 60.4%. Son actif total et son passif total sont NT$5.0B et de NT$2.7B. L'EBIT de BenQ Medical Technology est NT$349.1M ce qui fait que son ratio de couverture des intérêts 16.2. Elle dispose de liquidités et de placements à court terme de NT$992.5M.

Informations clés

60.4%

Ratio d'endettement

NT$1.36b

Dette

Ratio de couverture des intérêts16.2x
Argent liquideNT$992.49m
Fonds propresNT$2.25b
Total du passifNT$2.71b
Total des actifsNT$4.96b

Mises à jour récentes de la santé financière

Recent updates

There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Apr 07
There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

Mar 23
Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Mar 08
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

Feb 17
Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

Jan 29
BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 11
BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

Dec 24
The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Dec 07
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

Nov 17
Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 4116 ( NT$2.8B ) dépassent ses passifs à court terme ( NT$1.5B ).

Passif à long terme: Les actifs à court terme de 4116 ( NT$2.8B ) dépassent ses passifs à long terme ( NT$1.2B ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 4116 ( 16.3% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de 4116 est passé de 12% à 60.4% au cours des 5 dernières années.

Couverture de la dette: La dette de 4116 est bien couverte par le flux de trésorerie opérationnel ( 29.7% ).

Couverture des intérêts: Les paiements d'intérêts de 4116 sur sa dette sont bien couverts par l'EBIT ( 16.2 x couverture).


Bilan


Découvrir des entreprises saines